These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 1591301)
41. Allogeneic bone marrow transplantation: relation between chimaerism and immunity. Vossen J Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764 [TBL] [Abstract][Full Text] [Related]
42. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation. Lopez M; Mary JY; Sainteny F Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567 [TBL] [Abstract][Full Text] [Related]
43. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use. Watt SM; Austin E; Armitage S Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475 [TBL] [Abstract][Full Text] [Related]
45. Intra-Bone Marrow Transplantation of Endosteal Bone Marrow Cells Facilitates Allogeneic Hematopoietic and Stromal Cells Engraftment Dependent on Early Expression of CXCL-12. Chen C; Su Y; Chen J; Zhang D; Song Y; Guo S Med Sci Monit; 2015 Sep; 21():2757-66. PubMed ID: 26373579 [TBL] [Abstract][Full Text] [Related]
46. Bone marrow transplantation for Hodgkin's disease--recent advances and current issues. Champlin R Leuk Lymphoma; 1993; 10 Suppl():103-8. PubMed ID: 8481659 [No Abstract] [Full Text] [Related]
48. Rationale for purging in autologous stem cell transplantation. Gulati SC; Acaba L J Hematother; 1993; 2(4):467-71. PubMed ID: 7916249 [TBL] [Abstract][Full Text] [Related]
49. New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation. Shpall EJ; Stemmer SM; Bearman SI; Myers S; Purdy M; Jones RB Breast Cancer Res Treat; 1993; 26 Suppl():S19-23. PubMed ID: 7691269 [TBL] [Abstract][Full Text] [Related]
50. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies. Albin N; Douay L; Fouillard L; Laporte JP; Isnard F; Lesage S; Ozsahin H; Bardinet D; Najman A; Gorin NC Bone Marrow Transplant; 1994 Aug; 14(2):253-9. PubMed ID: 7994241 [TBL] [Abstract][Full Text] [Related]
51. Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries. Clarke E; Potter MN; Hale G; Waldmann H; Lankester A; Cornish JM; Steward CG; Marks DI; Oakhill A; Pamphilon DH Bone Marrow Transplant; 1998 Jul; 22(2):117-24. PubMed ID: 9707017 [TBL] [Abstract][Full Text] [Related]
52. Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation. Perlingeiro Beltrame M; Malvezzi M; Bonfim C; Covas DT; Orfao A; Pasquini R Cytotherapy; 2014 Jul; 16(7):976-89. PubMed ID: 24831839 [TBL] [Abstract][Full Text] [Related]
53. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow. Ericson SG; Colby E; Welch L; Ball ED Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982 [TBL] [Abstract][Full Text] [Related]
54. Rationale for large scale bone marrow hemopoietic stem cell manipulation. Menichella G; Pierelli L; Vittori M; Paoloni A; Foddai ML; Serafini R; Iacone A; Mango G Haematologica; 1991 Mar; 76 Suppl 1():3-6. PubMed ID: 1677911 [TBL] [Abstract][Full Text] [Related]
55. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission]. Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688 [TBL] [Abstract][Full Text] [Related]
56. Is our current strategy in manipulating hemopoiesis in autologous transplantation correct? To LB Stem Cells; 1993 Jul; 11(4):283-9. PubMed ID: 8104615 [TBL] [Abstract][Full Text] [Related]
57. Tumor cell purging and positive selection of hematopoietic stem cells. Gee AP J Clin Apher; 1992; 7(3):135-7. PubMed ID: 1363101 [No Abstract] [Full Text] [Related]
58. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias. Geller RB Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882 [TBL] [Abstract][Full Text] [Related]
59. Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patients. Ben-Yosef R; Or R; Naparstek E; Kapelushnik J; Samuels S; Slavin S; Nagler A Am J Clin Oncol; 1997 Aug; 20(4):419-23. PubMed ID: 9256903 [TBL] [Abstract][Full Text] [Related]
60. Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma. Vose JM; Armitage JO Hematol Oncol Clin North Am; 1993 Jun; 7(3):577-90. PubMed ID: 8102135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]